Keros Therapeutics Inc (KROS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 8 | 0 | 0 | 0 | 0 |
| Gross Profit | 8 | N/A | N/A | N/A | N/A |
| Operating Expenses | 43,288 | 41,337 | 38,869 | 31,960 | 27,976 |
| Operating Income | -43,280 | -41,337 | -38,869 | -31,960 | -27,976 |
| Other Income | 3,840 | 3,832 | 3,065 | 2,242 | 4,467 |
| Pre-tax Income | -39,440 | -37,505 | -35,804 | -29,718 | -23,509 |
| Net Income Continuous | -39,440 | -37,505 | -35,804 | -29,718 | -23,509 |
| Net Income | $-39,440 | $-37,505 | $-35,804 | $-29,718 | $-23,509 |
| EPS Basic Total Ops | -1.33 | -1.27 | -1.26 | -1.09 | -0.92 |
| EPS Basic Continuous Ops | -1.33 | -1.27 | -1.26 | -1.09 | -0.92 |
| EPS Diluted Total Ops | -1.33 | -1.27 | -1.26 | -1.09 | -0.92 |
| EPS Diluted Continuous Ops | -1.33 | -1.27 | -1.26 | -1.09 | -0.92 |
| EBITDA(a) | $-43,070 | $-41,146 | $-38,702 | $-31,833 | $-27,850 |